Cornelia Camara is a biochemist with more than 15 years of professional experience, primarily in the pharmaceutical industry, but also in the medical device field. Ms Camara is based in Nyon, near Geneva, is fluent in German, French and English, and holds a Master of Science degree from the University of Geneva.

Prior to joining the Donawa team, Ms Camara held positions with Ares Serono, gaining management experience in a GMP-compliant biochemistry laboratory, and Sanofi-Synthélabo, where she was Regulatory Affairs Officer, concerned principally with the development of neurological pharmaceutical European and US regulatory submissions.  She subsequently coordinated the business development (licensing in) department at Debiopharm, a Swiss drug development company specializing in oncology.

Working in the medical device sector, Ms Camara was Regulatory Affairs Manager at Medipol SA, a nanotechnology and medical device consultancy company, based in the scientific park of the Polytechnic School in Lausanne, where she assisted client companies with CE marking, risk management and standards compliance, together with project planning & management, and regulatory training for device start-up companies.

At Donawa Lifescience Consulting, Ms Camara can assist pharmaceutical and medical device companies with regulatory submissions, regulatory strategy development, and the elaboration of development plans for placing products on the European and US markets. Her background gives Ms Camara ideal experience for managing drug/device combination projects, and she also continues to collaborate with the Swiss Innovation Promotion Agency (CTI) for regulatory and quality management training of start-up companies.